menu search

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable ...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable ...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable ...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable ...

November 3, 2023, 11:30 pm

Oncolytics biotech inc. (oncy) q3 2023 earnings call transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY ) Q3 2023 Earnings Conference Call November 3, 2023 8:30 AM ET Company Participants Jon ...

November 3, 2023, 9:05 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first ...

November 3, 2023, 8:01 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a ...

November 3, 2023, 7:43 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...

November 3, 2023, 7:41 pm

Fed's bostic: policy is likely in the right place given the economic outlook

Pleased with jobs number, it's consistent with the outlookHoping for minimal pain for the economyFed has time to watch and be ...

November 3, 2023, 7:41 pm

Major shifts underway in market expectations for federal reserve interest rates

This week there have been some big shifts on the market's thinking around the path of Fed policy. Given...

November 3, 2023, 6:09 pm

Actinium pharmaceuticals: the trickle down continues, and i maintain a buy

Actinium Pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, which has potential beyond market expectations. Th...

November 3, 2023, 6:08 pm

Tradeweb's october average daily volume jumps 66%, driven by market volatility

The US-based electronic marketplace Tradeweb Markets reported a total trading volume of $37.2 trillion in October 2023. Its average daily volume (ADV)...

November 3, 2023, 6:02 pm

Doman building materials group ltd. (cwxzf) q3 2023 earnings call transcript

Doman Building Materials Group Ltd. (OTCPK:CWXZF) Q3 2023 Earnings Conference Call November 3, 2023 12:00 PM ET Company Participants Ali Mahdavi - Inv...

November 3, 2023, 5:59 pm

Valkyrie exec sees spot bitcoin etf approval this month

The Securities and Exchange Commission may approve the much-anticipated spot bitcoin ETF as soon as thi...

November 3, 2023, 5:44 pm

Got $3,000? 3 growth stocks to double up on right now

Robotic process automation, Uipath's specialty, is expected to grow rapidly over the next decade. Merca...

November 3, 2023, 5:20 pm

Usd/jpy forecast – us dollar pulls back after jobs number

The US dollar fell rather significantly during the trading session on Friday, as the jobs number came in quite a bit weaker than antici...

November 3, 2023, 4:55 pm

Gbp/usd forecast – british pound takes off

The British pound took off to the upside during the trading session on Friday as the jobs report in the United States came out much weaker than antici...

November 3, 2023, 4:46 pm


Search within

Pages Search Results: